ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Vir Biotechnology, INC.

Official 2024 U.S. DOL Form 5500 summary for Vir Biotechnology, INC. (Vir Biotechnology 401(k) Plan · EIN 81-2730369 · PN 001): $71.93M net assets, 370 active participants, and $13.76 per $10,000 (13.76 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorVir Biotechnology, INC.
Filing IdentifierVir Biotechnology 401(k) Plan · EIN 81-2730369 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$71.93M
Active Participants370
Direct Admin Fee Rate$13.76 per $10,000 (13.76 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI